Thromboembolic complications in Thai pediat patients

Journal of the Medical Association of Thailand

Volumn 84, Issue 5, 2001, Pages 681-687

  Chuansumrit, Ampaiwan ^a   Chiemchanya, Surang ^a   Khowsathit, Pongsak ^a   Hotrakitya, Satit ^a   Chunharas, Amornsri ^a   Hathirat, Phongjan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

DIC; Thromboembolism

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; MALE; MORTALITY; NEWBORN; PRESCHOOL CHILD; RECURRENT DISEASE; RETROSPECTIVE STUDY; THAILAND; THROMBOEMBOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RECURRENCE; RETROSPECTIVE STUDIES; THAILAND; THROMBOEMBOLISM;

EID: 0035346734     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fhornphibulaya P, Buranapong P, Ruksawin N, Viranuvatti J. The incidence of postoperative deep vein thrombosis in Thais. J Med Assoc Thai 1984; 67: 377-81.
2. Chumnijarakit T. Incidence of postpartum thromboembolism in Thai woman comparison with Western experience. J Med Assoc Thai 1974; 5: 592-4.
3. Atichartakarn V, Pathepchotiwong K, Keorochana S, Eurvilaichit C. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med 1988; 148: 1349-53.
4. Visudhiphan S. Trend of deep vein thrombosis in Thailand. Thai J Hematol Transf Med 1998; 8: 283-01.
5. Mahasandana C, Suvatte V, Chuansumrit A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990; 117: 750-3.
6. Laurell CB. Electroimmunoassay. Scan J Clin Lab Invest 1972; 29(Suppl 124): 21-7.
7. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72.
8. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-7.
9. Andrew P, Vegh P, Johnson M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 8: 1998-05.
10. Gerson WJ, Dixkerman JD, Bowil EG, Golden E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 1993; 91: 418-22.
11. Hathaway WE, Bonnar J. Hemostatic disorders of the pregnant women and newborn infants. New York: Elsevier, 1987: 57-75.
12. Nardi M, Karpatkin M. Prothrombin and protein C in early childhood. Normal adult levels are not achieved until the fourth year of life. J Pediatr 1986; 109: 843-5.
13. Manco-Johnson MJ, Abshire TC, Jacobson LJ, Marlar RA. Severe neonate protein C deficiency: prevalence and thrombotic risk. J Pediatr 1991; 119: 793-8.
14. Bick RL, Bick MD, Fekete LF. Antithrombin III pattern in disseminated intravascular coagulation. Am J Clin Pathol 1980; 73: 577-83.
15. Griffin JH, Masher DF, Zimmerman TS, et al. Protein C an antithrombotic protein is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261-4.
16. Marlar RA, Endres-Brook J, Miller G. Serial studies of protein C and its plasma inhibitor in patient with DIC. Blood 1985; 66: 59-63.
17. Takahashi H, Takakuwa E, Yoshion N, et al. Protein C level in disseminated intravascular coagulation and thrombotic coagulation parameters. Thromb Haemost 1985; 54: 445-9.
18. Evans DJ, Silverman M, Bowley NB. Congenital hypertension due to renal vein thrombosis. Arch Dis Child 1981; 56: 306-8.
19. Couser RJ, Mammel MC, Cofeman M, Boros SJ. Neonatal brachial artery occlusion from an umbilical cord tourniquet. J Pediatr 1984; 104: 286-9.
20. Wolfman WL, Purohit DM, Self SE. Umbilical vein thrombosis at 32 weeks' gestation with delivery of a living infant. Am J Obstet Gynecol 1983; 146: 468-70.
21. Mehls O, Andrassy K, Koderisch J, et al. Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr 1987; 110: 862-7.
22. Olson JC. Juvenile dermatomyositis. Semin Dermatol 1992; 11: 57-64.
23. Ronde HD, Bertina RM. Laboratory diagnosis of APC resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
24. Stefano VD, Chiusolo P, Paciaroni K, et al. Prothrombin G 20210 A mutation genotype is risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91: 3562-5.
25. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (letter). Nature Genetics 1995; 10: 111-3.
26. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597-00.
27. Prandoni P, Lensing AW, Bullen HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep vein thrombosis. Lancet 1992; 339: 441-5.
28. Hull RD, Raskok CE, Pinco GF. Subcutaneous low-molecular-weight heparin with continuous intravenous heparin in the treatment of proximal vein thrombosis. N Engl J Med 1992; 326: 975-82.
29. Chuansumrit A, Hotrakitya S, Kruavit A. Severe acquired neonatal purpura fulminans. Clin Pediatr 1996; 35: 373-6.